Nomura Healthcare Fund (DLHAX) is an MF managed by Independent / Boutique. Its largest position is UNITED COMMUNITY BANKS INC (UCB), representing 5.90% of fund assets.
Nomura Healthcare Fund Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- DLHAX
- Type:
- MF
- Manager:
- Independent / Boutique
- Total Assets:
- —
- Report Date:
- Mar 31, 2026
- Filing Date:
- May 28, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
UNITED COMMUNITY BANKS INC
|
5.90% | $39,209,853.79 | 130,137 |
|
-
REGENERON PHARMACEUTICALS, INC.
|
5.46% | $36,314,080.00 | 47,000 |
|
-
PFIZER INC
|
4.84% | $32,151,600.00 | 1,145,000 |
|
-
GILEAD SCIENCES, INC.
|
4.40% | $29,267,700.00 | 210,000 |
|
-
AbbVie Inc.
|
4.09% | $27,186,250.00 | 125,000 |
|
-
Merck & Co., Inc.
|
3.89% | $25,862,350.00 | 215,000 |
|
-
ASTRAZENECA PLC
|
3.86% | $25,663,255.84 | 131,243 |
|
-
CHUGAI PHARMACEUTICAL CO LTD.
|
3.73% | $24,816,817.63 | 450,000 |
|
-
ELI LILLY & Co
|
3.60% | $23,914,020.00 | 26,000 |
|
-
ROPER TECHNOLOGIES INC
|
3.30% | $21,949,996.36 | 55,000 |
|
-
UNITEDHEALTH GROUP INC
|
2.85% | $18,941,300.00 | 70,000 |
|
-
Elevance Health, Inc.
|
2.77% | $18,443,250.00 | 63,000 |
|
-
AMGEN INC
|
2.49% | $16,536,950.00 | 47,000 |
|
-
Viatris Inc
|
2.38% | $15,806,943.18 | 1,170,018 |
|
-
BOSTON SCIENTIFIC CORP
|
2.36% | $15,687,500.00 | 250,000 |
|
-
HALOZYME THERAPEUTICS, INC.
|
2.14% | $14,218,600.00 | 220,000 |
|
-
Banco Santander, S.A.
|
1.74% | $11,588,379.42 | 120,000 |
|
-
VERTEX PHARMACEUTICALS INC / MA
|
1.68% | $11,163,500.00 | 25,000 |
|
-
ILLUMINA, INC.
|
1.67% | $11,093,400.00 | 90,000 |
|
-
Viking Therapeutics, Inc.
|
1.62% | $10,741,454.00 | 330,100 |
|
-
Alkermes plc.
|
1.54% | $10,254,400.00 | 290,000 |
|
-
ALNYLAM PHARMACEUTICALS, INC.
|
1.49% | $9,926,100.00 | 30,000 |
|
-
FEDERAL NATIONAL MORTGAGE ASSOCIATION FANNIE MAE
|
1.42% | $9,438,000.00 | 1,300,000 |
|
-
Roivant Sciences Ltd.
|
1.41% | $9,367,613.70 | 338,181 |
|
-
NEUROCRINE BIOSCIENCES INC
|
1.39% | $9,221,800.00 | 70,000 |
|
-
Cogent Biosciences, Inc.
|
1.33% | $8,852,700.00 | 230,000 |
|
-
Arcus Biosciences, Inc.
|
1.23% | $8,188,560.00 | 379,100 |
|
-
INCYTE CORP
|
1.13% | $7,529,600.00 | 80,000 |
|
-
ZIMMER BIOMET HOLDINGS, INC.
|
1.09% | $7,233,600.00 | 80,000 |
|
-
Tarsus Pharmaceuticals, Inc.
|
1.05% | $7,015,000.00 | 100,000 |
|
-
FEDERAL HOME LOAN MORTGAGE CORP
|
1.01% | $6,720,000.00 | 1,050,000 |
|
-
QUEST DIAGNOSTICS INC
|
0.88% | $5,879,400.00 | 30,000 |
|
-
BIOMARIN PHARMACEUTICAL INC
|
0.85% | $5,649,000.00 | 100,000 |
|
-
CVS HEALTH Corp
|
0.81% | $5,386,500.00 | 75,000 |
|
-
MSILF GOVERNMENT PORTFOLIO
|
0.81% | $5,357,802.07 | 5,357,802 |
|
-
BLACKROCK LIQUIDITY FUNDS
|
0.81% | $5,357,802.07 | 5,357,802 |
|
-
GOLDMAN SACHS FINANCIAL SQUARE
|
0.81% | $5,357,802.07 | 5,357,802 |
|
-
FIDELITY GOVERNMENT PORTFOLIO
|
0.81% | $5,357,802.07 | 5,357,802 |
|
-
ANAPTYSBIO, INC
|
0.78% | $5,198,376.72 | 93,732 |
|
-
BIOGEN INC.
|
0.77% | $5,133,240.00 | 28,000 |
|
-
Abivax S.A.
|
0.75% | $5,010,750.00 | 45,000 |
|
-
STRYKER CORP
|
0.74% | $4,928,850.00 | 15,000 |
|
-
JOHNSON & JOHNSON
|
0.74% | $4,888,800.00 | 20,000 |
|
-
Vir Biotechnology, Inc.
|
0.67% | $4,480,000.00 | 500,000 |
|
-
GRAIL, Inc.
|
0.66% | $4,392,800.00 | 85,000 |
|
-
RIGEL PHARMACEUTICALS INC
|
0.65% | $4,326,400.00 | 160,000 |
|
-
uniQure N.V.
|
0.63% | $4,221,749.85 | 258,211 |
|
-
Syndax Pharmaceuticals Inc
|
0.63% | $4,204,800.00 | 180,000 |
|
-
MADRIGAL PHARMACEUTICALS, INC.
|
0.55% | $3,664,290.00 | 7,000 |
|
-
Theravance Biopharma, Inc.
|
0.51% | $3,388,548.09 | 208,783 |
Advertisement (320x50)